Intracavernosal Injection Therapy: An Overview

Introduction:

Erectile dysfunction (ED), characterized by the difficulty in sustaining an erection during sexual intercourse, is a prevalent issue. Research indicates that over half of the male population, specifically around 52 percent, experience this condition. This condition is multifaceted, with contributing factors such as age, lifestyle choices, psychological influences, and physical health issues. Available therapies range from hormone replacement and oral PDE5 (phosphodiesterase-5) inhibitors to topical gels, sex therapy, and the use of external vacuum pumps for erectile dysfunction. Intracavernosal injection therapy is renowned for its effectiveness in treating erectile dysfunction. This article provides an in-depth look at its indications, contraindications, procedural steps, and side effects.

What Is Intracavernosal Injection Therapy?

Intracavernosal injection therapy, a form of penile injection therapy, delivers medications into the penis that addresses erectile dysfunction or impotence, assisting those who are unable to achieve an erection firm enough for sexual activity. During this procedure, a vasodilatory agent is introduced into the corpus cavernosum, a significant spongy column within the penile structure. This area, dense with blood vessels, supports the erection process by ensuring smooth blood circulation. The medications utilized in this treatment typically consist of a blend of two or three different agents:

• Prostaglandin E1.

• Phentolamine.

• Papaverine.

• Alprostadil.

These drugs, used in intracavernosal injection therapy, facilitate the relaxation of penile smooth muscles and boost blood circulation, typically leading to erections within 10 to 15 minutes. The therapy is notably effective and can be personalized regarding concentration and formulation. Typically, a combination of two or three medications is employed in this therapy. For example, trimix includes Phentolamine, Papaverine, and Alprostadil, while Bimix consists of Phentolamine and Papaverine. Erections can be achieved in up to 60 to 70 percent of patients using this therapy, and roughly 70 percent of individuals will require continued therapy for sustained results.

What Is the Procedure Involved in Intracavernosal Injection Therapy?

A urologist carries out the intracavernous injection and provides instructions for at-home use over two office visits. The procedure, demonstrated by the doctor, involves the patient or their partner injecting the medication into the corpus cavernosum using a fine-gauge diabetic needle, targeting the mid-shaft at a 10 o'clock or 2 o'clock angle. After administering the injection, an erection usually develops within five to 15 minutes and endures for approximately 30 to 40 minutes. The process includes these steps:

• Start by sanitizing the area to set up the supplies. These supplies include the medication syringe, vile, wipes, and a sharp container.

• Cleanse the hands using soap and water.

• After uncapping the medication, it is important to sanitize the rubber top with an alcohol pad to prevent bacterial contamination.

• With the syringe detached, insert it through the rubber stopper and retract the plunger to pull up the medication to the recommended dosage.

• Verify the syringe for the presence of air bubbles. Should any appear, they must be removed.

• Wipe the intended injection site with alcohol, then proceed to administer the injection in the middle third of the penis, targeting the 2 o'clock or 10 o'clock angle.

• Post-injection, maintain steady pressure on the injection site for two to three minutes.

To ensure safe use of this therapy, consider the following precautions beforehand:

• Steer clear of Sildenafil, Vardenafil, and Avanafil for 18 hours before and following the injection.

• After using Tadalafil, refrain from receiving an injection for a minimum of three days and seek advice from the healthcare provider.

• Trimix injections should be kept in the refrigerator and protected from light. Bimix can be stored at room temperature.

• Discard the injection if it turns cloudy or if the rubber stopper has come off.

• Do not administer the injection into easily visible veins, as this could result in bruising.

• Do not administer injections to the upper or lower areas of the penis.

• Refrain from changing the dosage without guidance.

• Do not administer the injection more than once within 24 hours.

• Do not administer a second injection if the first one is ineffective.

When Is Intracavernosal Injection Therapy Indicated?

Intracavernosal injection therapy serves as a backup option for managing erectile dysfunction and is recommended when oral treatments are not viable or fail to produce results. The following situations warrant its use:

• When oral treatments, including PDE5 inhibitors such as Sildenafil, Vardenafil, and Tadalafil, fail. The mechanism of action of phosphodiesterase 5 inhibitors works by blocking the enzyme phosphodiesterase type 5 to enhance blood flow and support erections.

• In cases of neurogenic erectile dysfunction, where nerve damage leads to erectile issues and constitutes 10 to 19 percent of all ED cases, treatment can achieve a 100 percent success rate.

• Vascular erectile dysfunction, caused by reduced blood flow and indicative of cardiovascular disease, affects around 30 percent of individuals. The success rate for treatment in these cases typically ranges from 60 to 70 percent.

• Following a prostatectomy, the removal of the prostate gland, which produces fluids that nourish and protect sperm, can lead to changes in erectile function.

• Damage to the spinal cord can lead to issues with erectile function.

• Erectile dysfunction related to diabetes, particularly in individuals who use insulin.

What Are the Contraindications of Intracavernosal Injection Therapy?

Conditions that contraindicate the use of intracavernosal injection therapy include:

• Elevated blood pressure that remains uncontrolled.

• Presence of heart-related conditions.

• The co-use of monoamine oxidase inhibitors (MAOIs).

• Medical conditions like arthritis (causing swollen joints, limited mobility, and pain), or neurological disorders that affect hand control.

• Having a psychiatric disorder, including schizophrenia (a mental illness that impacts a person's thoughts and behaviors.).

• Severe venous leakage in which the veins in the penis fail to adequately hold blood during an erection.

• Presence of abnormalities in the penis.

• Infections affecting the genital region.

• Sickle cell anemia.

• Allergic responses to the medications administered in intracavernosal injection therapy.

• Priapism features an unbearable erection that endures for three to four hours and occurs in the absence of sexual stimulation.

• When using anticoagulant medications.

What Are the Side Effects of Intracavernosal Injection Therapy?

The following side effects may occur with intracavernosal injection therapy:

• Scarring may occur if the injection is not performed correctly.

• Experiencing pain in the penis when erect.

• Localized bruising around the injection point.

• The treatment can also lead to priapism, a condition characterized by prolonged and painful erections, which is managed with an antidote. This includes four tablets of 30 milligrams of Pseudoephedrine HCl.

• Bleeding at the site following the injection.

• Injection site responses, including lumps or itching.

Conclusion:

The advancement of intracavernosal injection therapy represents a significant leap in managing erectile dysfunction. This method involves injecting vasoactive substances directly into the erectile tissue. To maximize effectiveness, it is important for patients to receive thorough education and to use the technique accurately. When used as directed, this therapy is generally safe, with about 80 percent of patients responding favorably.